Gwangju, South Korea

Hoo-kyun Choi

This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Taho Pharmaceuticals Ltd., Industry-Academic Cooperation Foundation, Nal Pharmaceuticals, Ltd.. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hoo-kyun Choi. Retrieved from https://idiyas.com/inventor/hoo-kyun-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **The Innovations of Hoo-kyun Choi: A Pioneer in Transdermal Drug Delivery Systems**

Introduction

Hoo-kyun Choi, an accomplished inventor based in Gwangju, South Korea, has made significant contributions to the field of pharmaceutical technology through his innovative work on transdermal drug delivery systems. With a total of three patents to his name, Choi has advanced the methods of delivering essential medications directly to the bloodstream, enhancing patient comfort and drug efficacy.

Latest Patents

Choi's most recent inventions focus on transdermal systems that utilize advanced materials for effective drug delivery. One of his notable patents is the "Transdermal delivery system containing galantamine or salts thereof." This invention features a drug-containing matrix layer that comprises galantamine or its pharmaceutically acceptable salt as an active ingredient, paired with a styrene-butadiene-styrene copolymer or a styrene-isoprene-styrene copolymer serving as an adhesive. Additionally, he developed a "Transdermal drug delivery system containing donepezil," which also consists of a drug-containing matrix layer featuring donepezil or a pharmaceutically acceptable salt and utilizes an acrylate-rubber hybrid as an adhesive. These innovations demonstrate Choi's commitment to improving how drugs are administered and absorbed by the body.

Career Highlights

Throughout his career, Hoo-kyun Choi has worked for several reputable organizations, including Taho Pharmaceuticals Ltd. and the Industry-Academic Cooperation Foundation. His roles in these institutions have allowed him to refine his skills in research and development, contributing significantly to advancements in the pharmaceutical industry.

Collaborations

Choi has collaborated with notable professionals in his field, including Myung-kwan Chun and Y Joseph Mo. These partnerships have fostered a creative environment that encourages innovation and excellence in drug delivery technology.

Conclusion

Hoo-kyun Choi's work exemplifies the spirit of innovation in the pharmaceutical domain. Through his patents and collaborations, he has paved the way for enhanced drug delivery methods that prioritize patient comfort and treatment efficiency. As the landscape of pharmaceutical technology evolves, Choi's contributions remain invaluable, pushing the boundaries of how medications can be effectively delivered.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…